Tag: Pivotal

The luxury goods market is projected to soar to USD 704.95 billion by 2033, exhibiting a robust CAGR of 7.02% from 2025. This growth is driven by rising disposable incomes, expanding middle-class demographics, and increasing brand recognition. Prominent trends include digital transformation, experiential and personalized luxury, and sustainable practices. The market analysis covers diverse segments such as watches and jewelry, perfumes, cosmetics, clothing, and accessories. Key regions like China, India, the U.S., and Saudi Arabia are pivotal growth anchors, with companies like Kering, Ralph Lauren, and Hermès leading strategic expansions.

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI^® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.¹